2597-29-7

Basic information

• Product Name: 3-ethylideneindolin-2-one
• Synonyms: 3-ethylideneindolin-2-one;(Z)-3-ethylideneindolin-2-one
• CAS NO: 2597-29-7
• Molecular Formula: C₁₀H₉NO
• Molecular Weight: 159.18
• Mol File: 2597-29-7.mol
• Article Data: 5

Chemical Properties

• Melting Point: 165 °C
• Boiling Point: 362.0±35.0 °C(Predicted)
• Appearance: /
• Density: 1.241±0.06 g/cm3(Predicted)
• PKA: 12.79±0.20(Predicted)
• CAS DataBase Reference: 3-ethylideneindolin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-ethylideneindolin-2-one(2597-29-7)
• EPA Substance Registry System: 3-ethylideneindolin-2-one(2597-29-7)

Safety Data

• Hazardous Substances Data: 2597-29-7(Hazardous Substances Data)

Upstream product

• 59-48-3 2-oxoindole 
• 75-07-0 acetaldehyde 
• 91-56-5 indole-2,3-dione 
• 1754-88-7 ethylenetriphenylphosphorane 

Downstream Products

• 15379-45-0 3-ethyloxindole 

Relevant articles and documents

Visible light induced hydrodifluoromethylation of alkenes derived from oxindoles with (difluoromethyl)triphenylphosphonium bromide

A visible light induced hydrodifluoromethylation of alkenes derived from oxindoles with (difluoromethyl)triphenylphosphonium bromide was developed. This reaction delivers a series of previously unknown difluoromethylated oxindoles containing C–CF2H quaternary centers in moderate to excellent yields. The resulting CF2H-containing oxindoles are potentially useful in drug discovery.

Biocatalysed olefin reduction of 3-alkylidene oxindoles by baker's yeast

3-Substituted oxindoles are very interesting molecules both for their potential biological activity and for their role as starting materials toward more complex oxindole-based structures. These molecules can be prepared by the reduction of a 3-ylidene oxi

NOVEL COMPOUNDS

The present invention relates to new CGRP-antagonists of general formula I wherein U, V, X, Y, R1, R2, R3 and R4 are defined as mentioned in the description, the tautomers thereof, the isomers thereof, the diastereomers thereof, the enantiomers thereof, the hydrates thereof, the mixtures thereof and the salts thereof as well as the hydrates of the salts, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, medicaments containing these compounds, the use thereof and processes for the preparation thereof.